Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr;40(2):125-135.
doi: 10.1007/s10585-023-10203-z. Epub 2023 Apr 10.

CD44 in Bone Metastasis Development: A Key Player in the Fate Decisions of the Invading Cells?

Noy Shir Zer  1 , Noa Ben-Ghedalia-Peled  1 , Levi A Gheber  1 , Razi Vago  2
Affiliations
Review

CD44 in Bone Metastasis Development: A Key Player in the Fate Decisions of the Invading Cells?

Noy Shir Zer et al. Clin Exp Metastasis. 2023 Apr.

Abstract

A participant in key developmental processes, the adhesion glycoprotein CD44 is also expressed in several types of malignancies and can promote metastasis. In addition, the expression of CD44 isoforms in different types of cancer such as prostate and breast cancers may facilitate bone metastases by enhancing tumorigenicity, osteomimicry, cell migration, homing to bone, and anchorage within the bone specialized domains. Moreover, there is evidence that the CD44-ICD fragments in breast cancer cells may promote the cells' osteolytic nature. Yet the mechanisms by which CD44 and its downstream effectors promote the establishment of these cells within the bone are not fully elucidated. In this review, we summarize the current data on the roles played by CD44 in cancer progression and bone metastasis and the possible effects of its interaction with the different components of the bone marrow milieu.

Keywords: Bone metastasis; Breast cancer; CD44; Dormancy; Metastasis; Osteomimicry; Prostate cancer.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Isacke CM, Yarwood H (2002) The hyaluronan receptor, CD44. Int J Biochem Cell Biol 34:718–721 - PubMed
    1. Naor D, Sionov RV, Ish-Shalom D (1997) CD44: structure, function and association with the malignant process. Adv Cancer Res 71:241–319 - PubMed
    1. Chen C, Zhao S, Karnad A, Freeman JW (2018) The biology and role of CD44 in cancer progression: therapeutic implications. J Hematol Oncol 11:1–23
    1. Draffin JE, Hill A, Johnston PG, Waugh DJ (2003) CD44 expression on prostate cancer cells correlates with adhesion to bone marrow endothelial cells. Clin Cancer Res 9:6181S
    1. Draffin JE, McFarlane S, Hill A, Johnston PG, Waugh DJ (2004) CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Res 64:5702–5711 - PubMed

LinkOut - more resources